INTRODUCTION
Although there are some comparative studies of the botanical content and patterning of phytopharmacopoeias across different ecological zones and between ethnolinguistic areas, these are few in number (Heinrich 1998 (Heinrich : 1859 Moerman et al. 1999) , while there are even fewer attempts to compare these systematically within the same cultural and ecological zone. This paper undertakes a simple quantitative survey of the medicinal plant resources of three populations on the island of Seram in eastern Indonesia for which we have suficient ethnographic and environmental data, and who speak related but different Ambon-Timor languages. The three groups are: Manusela, Alune and Nuaulu. In order to further test observations based on the three Seramese studies, the results are then compared with studies from ive different populations on the island of Borneo: Brunei Dusun, Ransa Dayak, two groups of Kenyah Dayak and Penan Benalui. The aim is to examine the extent to which it is possible to identify a common 'core' of plants that represent the phytomedical resource base of a wider ethnomedical tradition, and to develop a model of medicinal plant 'resource pools' to aid comparison. While we might expect close similarities between medicinal loras of populations that are geographically, ecologically, and culturally close, the paper discusses explanations (including levels 346 / Ellen and Puri of acculturation, degree of access to biomedical provision, but above all; differing methodologies) for lack of expected congruence. Work on island Southeast Asia generally (for example the PROSEA project: Padua et al. 1999; Valkenburg et al. 2002; Lemmons et al. 2003 ) might lead us to expect a core of shared plants for all areas that are part of a regional folk medical tradition. To this end, we compare the lists derived from the eight ield sites with a list of medicinal plants provided by Slikkerveer and Slikkerveer (1995) , and as used by TOGA, an NGO committed to encouraging the use of traditional Indonesian medicinal plants, and focussed mainly on Java. Of a total estimated Indonesian lora of 28,000, 1000 species are estimated as being used as medicinals (Padua et al. 1999: 55) .
While biodiversity loss is evident in the areas where the studies have been conducted, and this may impact on some actual and more potential medicinal plants; we suggest in conclusion that it is less likely to impact on core ethnopharmacopoeias.
THE STUDY SITES
Seram lies in the Indonesian province of Maluku (the Moluccas), east of Wallace's line and in the Australasian loral area ( Figure 1a ). It has a varied forest structure and loral composition, and-for example-is characterised by few dipterocarps and more eucalypts compared with islands to the West (Ellen 2007) . The Manusela study (Bell and van Houten 1993) was conducted between July-December in an ecologically diverse group of villages, ranging from Hatumeten on Teluti Bay on the southern coast, the upland villages around Manusela, and the northern lowland Huaulu villages of Huaulu and Alakamat. These are mixed animist and Christian groups living at various altitudes in central Seram who share a language, though with dialectal differences between Huaulu and Manusela. The overall population estimate is 7,300 (Atlas Bahasa Tanah Maluku 1996: 58) . The second study Wolff and Florey 1998; Florey 2001) , was conducted in two Alune villages of west Seram: Lohiatala (3° 09' S, 128° 22' E) and Lohiasapalewa (2° 53' S, 128° 20' E), located respectively near the coast at sea-level, and at an altitude of 650 meters in the central mountain spine. These villages comprise acculturated Christian populations living on the rainforest edge. The number of Alune speakers is around 13,000, and the populations of Lohiatala and Lohiasapalewa, respectively 728 (1992) and 244 (1998) . The third study focusses on the phytomedical resources of the Nuaulu village of Rouhua located on the south coast in the Amahai subdistrict (3° 21' S, 129° 08' E) of central Seram, but extracting from a varied forest landscape extending to the central mountain range. The Nuaulu are predominantly animist, and in 2009 numbered over 2000, the population of Rouhua being 508. Ethnobotanical data, including herbarium specimens were collected during ield visits between 1970 and 2003, but mainly in 1996 . Of the three studies, this last is the most comprehensive ethnobotanically, although without a speciic medicinal plant focus. All three Seram cases are of populations engaged in a similar combination of subsistence practices: sago extraction, swidden cultivation, forest gathering, and hunting, although Nuaulu likely engage in more hunting than the other two. Access to modern medicines has grown over four decades, with Nuaulu and Manusela populations more reliant on herbal remedies than Alune. Overall, all three studies report data for populations that have knowledge of a range of biotopes, and where medicinal plants are theoretically available from varied habitats.
Of the ive Borneo studies (Figure 1b) At the time of most of these studies (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) , villages
were small--between 80 and 400 people--and reliant on rice swidden agriculture, gardening, hunting, ishing, and the collection on NTFPs and some government wage labour. The area is remote, not serviced by roads, and residents rely on government clinics for biomedical care, from which staff travel regularly to more remote villages. Medical ethnobotanist Leaman (Leaman 1996) Puri (2001 Puri ( , 2005 and Koizumi (2007) Slikkerveer and Slikkerveer 1995) but include ferns such as the widely used polypods. To make the taxa comparable we have departed from Cronquist's (1981) arrangement, as modiied by Mabberley (1987) , and have conirmed the accepted names using The Plant List (2013), an online collaborative effort by Royal Botanic Gardens (RBG) Kew and Missouri Botanical Garden, plus other institutions, to aggregate existing plant lists and distinguish accepted names and synonyms for all vascular plants and bryophytes.
In terms of family names, we use A rather than
rather than G ; and include U in A , and C in Z . We have checked [Downloaded free from http://www.conservationandsociety.org on Thursday, January 05, 2017, IP: 80.189.5.13] and corrected for synonyms, and updated where necessary. In cases where names have been misspelled in the original sources (sometimes leading to family misattributions) these have been changed to conform with The Plant List. In compiling and checking initial lists we have also used Mabberley (1987) , and the PROSEA volumes (especially volumes 12(1), 12(2), and12 (3): see Padua et al. 1999; Van Valkenburg and Bunyapraphatsara 2002; Lemmens and Bunyapraphatsara 2003) . The taxa in the TOGA list too have been revised in the ways described.
Given that the lists used contain relatively small numbers of species, from the point of view of statistical inference even small changes in nomenclature and taxonomic status may have a disproportionate effect on ratios and percentages calculated. This might result from a failure to recognise synonyms, or-depending on the study or method of data collectionmay hinge on a decision to include or exclude a common edible plant (such as the banana Musa x paradisiaca L.) as a medicinal. Also, if an undetermined species of a known genus turns out to be a species that is otherwise common (e.g. if Ransa Zingiber sp. is really Z. oficinale Roscoe), this may have a similar effect.
The eight studies illustrate the kinds of problems encountered in comparing medicinal loras at the local and regional level, from data collected at different times, and one might add ield methodological issues and research protocols more generally in medical ethnobotany (Heinrich et al. 2009 ). Lemmens and Bunyapraphatsara (2003: 24-27 ) also acknowledge the paucity of medicinal plant data for speciic locations in island Southeast Asia using modern ethnobotanical methods.
The main problem with the studies examined here, as with many others, is that data were not assembled under comparable conditions: researchers came from different disciplinary backgrounds with different research priorities, were in the ield and actively collecting specimens for different lengths of time, were collecting specimens from different zones, and not according to a common and not always transparent methodology. The studies by Ellen and Puri provide a cumulative list of plants reported over a period, using data and vouchers obtained in a variety of contexts by a large number of non-specialist consumers of medicinal plants. The approach was broadly anthropological, with increasing attention being paid to ethnobotanical subjects over time. The study by Florey and Wolff is largely conducted by a linguist with the assistance of a botanist. As far as can be judged from the published output, the data were assembled in a way broadly similar to Ellen, though over a shorter time interval. We know even less of the Manusela study, though it was conducted in three locations over a relatively short period, and without mention of a particular disciplinary perspective. Of the Borneo studies, that amongst the Ransa Dayak systematically sampled forest plots, and was explicitly ecological in approach. The Dusun study used a combination of plots in different areas, and was conducted by a biogeographer with considerable experience in ethnobotany. The two Kenyah studies and Koizumi's Penan study were perhaps the most rigorous and comprehensive, conducted over a long stint of continuous ieldwork by PhD students, all with substantial botanical and ethnobotanical training, and based on systematic collection of voucher specimens and interviews with multiple informants.
In all cases it is impossible to make judgments about species ranking on the basis of frequency of use, as there is no evidence on harvesting or treatment episodes; neither are there data based on freelisting with healers or ordinary community members. All we have are data on the multiple use of individual species, and general qualitative statements on the importance of particular species. Nor do we have reliable data on intracultural consensus, and in only a few cases do we have plants organised according to particular categories of illness (Leaman 1996; Gollin 2001; Koizumi 2005) . Moreover, the lists used are of species where there is a clear report of a medicinal use. In many cases the same species may exist at different research sites included in our study and be used in other ways although with no report that it is used as a medicinal. This is the case for Alstonia scholaris (L.) R. Br, Arenga pinnata (Wurmb.) Merr, Bixa orellana L. and Carica papaya L. among the Nuaulu, and many genera of food plants among the Kenyah, such as Annona, Citrus, Ipomoea, Mangifera, Musa, and Oryza. Similarly, in some cases it may be suspected that several species of a genus may substitute for one clearly reported species on the grounds of other contextual evidence for cultural uses. Thus, as many as seven closely related species of Piper are used by Nuaulu as occasional substitutes for Piper betle L. in the betel quid (Ellen 1991: 102) and it might be supposed that these potentially share many of the same medicinal uses.
As Heinrich et al. (1998 Heinrich et al. ( : 1868 and others have pointed out, standardised methodologies are important in comparative evaluation, but we are often handicapped by the form in which our data are presented. Given the different ways data in the studies examined were assembled, and given uncertainties as to whether we are dealing with 'complete' lists, the method of calculating overlapping taxa developed here may have some advantages. It is, however, no substitute for studies conducted according to clear methodological criteria that allow us to compare the medicinal plants for particular human populations in terms of their ecological distribution, abundance, importance in terms of medicinal use categories, number of treatment episodes registered, variation in use between households, between specialist healers and non-healers, and overall cultural signiicance (Berlin and Berlin 2005) .
DISCUSSION The Seram studies compared
If we look at columns 1, 2, and 3 of the Appendix for the three Seram studies, only six species are reported as used medicinally in all three areas: Areca catechu L., Cocos nucifera L., Nicotiana tabacum L., Piper betle L. Urena lobata L. and Urticastrum decumanum (Roxb.) Kuntze. This is a remarkable result given the geographical and cultural proximity of these There are now several studies demonstrating that in the tropics medicinal plants are disproportionately harvested from disturbed secondary forest and non-forested areas (Stepp 2004; Voeks 1996 Voeks , 2004 , and we might expect that on Seram the most commonly used phytomedicines would be taken from domesticates or cultivated plants, either where these are well-established domesticates with other uses, or where wild medicinals have been deliberately cultivated or managed (Heinrich et al. 1998 (Heinrich et al. : 1869 (Florey and Wolff 1998: 46, 49) . Such examples show how dificult it can be to separate plants used speciically because of their known bioactive properties from those that are important symbolically as part of a treatment, such as A. catechu and P. betle.
In the Nuaulu case (Ellen 1991 ) these latter are part of a complex system for symbolising social interaction. The irst is used to treat diarrhoea and other intestinal disorders such as tapeworm and as a bactericide effective against dental caries and plaque, while the leaves of the second are used to treat ulcers, boils, bruises, and to clean wounds. The masticated quid comprising both, combined with mineral lime, serves as a mild antiseptic pressed into open wounds and ulcers; forming a kind of artiicial scab tissue. Other species may be symbolically essential but cannot be shown to have a direct pharmacological effect, while the medicinal properties of others are concealed as the plant is used for other purposes entirely; such as for food or as a cosmetic. It is for this reason that Etkin (1994: 65) has recommended multi-contextual approaches, which have now become the ethnopharmacological benchmark (Heinrich et al. 2009 (Table 2) , the number increases to 34 (Table 3) .
All the remaining species are reported in only one of the three studies ( There are some surprising differences between the Bornean groups, with Dusun reporting far fewer plants for top-ranked families. A and A , which are the families ranked 5 and 7 overall, are not reported for Dusun at all. M is ranked 5 for Kenyah Leppo Ke, but far down the ranking for all other groups and not reported at all for Dusun. Penan, like Kenyah Leppo Ke and Ransa, had many more species in the top-ranked families than Dusun, who appear to have a more even distribution across the families. Kenyah Uma Tukung reported 20 species of Z and had a less even distribution across the families than the others. Urticastrum decumanum (Roxb.) Kuntze is found throughout Southeast Asia but is only reported as being used in our Moluccan studies.
Medicinal plants and biodiversity across Wallacea
Overall, the eight field studies we have used comprise medicinal plants from 120 families, 367 genera, and approximately 617 separate species. The three Seram studies cover 65 families, 128 genera, and 169 species, while the ive Borneo studies cover 110 families, 323 genera, and 506 species. Taken together, the eight Seram and Borneo studies share four families (Z , F , E , and R ), and no genera (Ficus, Curcuma, and Costus are found in seven out of eight; while seven species are found in six out of eight). However, if we compute taxa shared between at least one population on Seram and one on Borneo we ind 55 families, 82 genera, and 56 species ( Table 7) .
Although we suspect that the methodology employed by Caniaga and Siebert, Leaman and Gollin has contributed to particularly long lists for the Ransa and Kenyah Dayak (expert healers interviewed over extended periods), differences between Borneo and Seram numbers relect what we might expect given the decrease in overall biodiversity between the forests of Borneo and Seram, as we traverse the Wallace line from one centre of botanical diversity in western Malesia to New Guinea. Number of vascular plants reported for Seram is low compared with either side of Wallacea, and although the database is still poor, if we take the example of number of fern species, those for Seram are estimated at about 534, compared with 1000 for Borneo and 2000 for New Guinea. Overall number estimates for vascular plant species for Borneo are around 16,000, compared with 15-20,000 for New Guinea, and 2000 for Seram (Edwards 1993: 5; MacKinnon et al. 1997; Monk et al. 1997) . Of a total estimated Indonesian lora of 28,000; 1000 species are judged as medicinals (Padua et al. 1999: 55) , so we can see that the ratio for Seram at 1:12 is far higher than that for Borneo at 1:71, which is what we might expect (Figure 2 
General studies of medicinal plants in southeast Asia
To obtain a regional overview of plant medicinals in southeast Asia we used the PROSEA (Plant Resources of Southeast Asia) series, particularly the three volumes on medicinal and poisonous plants. Lemmens and Bunyapraphatsara (2003: 23) admit that the means by which species were selected for inclusion in these volumes was on the whole subjective and 
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arbitrary, based on earlier lists such as those of Burkill (1935) and Heyne (1913-17) , with most of the 'important species' described in 12(1) and the 'least important' in 12(3). There are many other important medicinal plants, but these are regarded as having other primary uses, and therefore were included in other PROSEA volumes, but summarised in volume 12(1): 425-74. Lemmens and Bunyapraphatsara (2003: 27) estimate the number of southeast Asian species with recorded medicinal uses in the literature at 2,200. Because it is precisely these multi-purpose species that are often prioritised by local people living in rural areas, the PROSEA lists are therefore biased against highlighting the most important species used medicinally overall by virtue of the grouping strategy employed. Nevertheless, if we look at PROSEA data, the most important families in terms of number of genera reporting medicinal uses are A ,
and A . Lemmens and Bunayapraphatsara (2003: 27-8) estimate that of the 'more important' medicinals (a qualitative judgment); 10 percent come from cultivated habitats, 59 percent from open habitats ('wild'), and 31 percent from forest habitats.
General studies of traditional medicines in Indonesia have suggested the use of the same species across a wide area (Slikkerveer and Slikkerveer 1995: 21) . Many of these region-wide remedies have been shared for many hundreds of years if not longer, but others have spread widely in recent centuries through introductions from other parts of the world, and through dissemination of jamu therapy within Indonesia (Afdhal and Welsch 1988) . Jamu are ready-made herbal medicines, both homemade and supplied by healers, nowadays produced commercially and through small-scale home industries, augmented by do-it-yourself publications (Slikkerveer and Slikkerveer 1995: 13, 15 ). Many plants (Tables 8 and 9 ). Of the seven families; 29 genera, and 40 species are found only on the TOGA list (Table 10) , while most of the latter are of pan-tropical distribution or introduced, and more than half either cultivated or found in disturbed areas. Part of this overlap is due not only to the movement of both plants and therapeutic knowledge between different local populations, but also to the inluence of other medicinal systems, such as those of India and China, and of cosmopolitan biomedicine (Dunn 1977) . Figure 3 shows the results of a similarities test of all species identiied in the eight cases plus the TOGA list. It does not include 98 taxa identiied to genus level only. A simple presence/ absence species-by-case matrix was created in EXCEL and imported into ANTHROPAC (Borgatti 1996) , where a proximity matrix was calculated using a positive matching procedure and the cases compared, which was then graphed in two dimensional space using multidimensional scaling (MDS). In the MDS plot, the shorter the distance between cases the more similar are their lists of medicinal plant species. Figure 4 shows the results of a correspondence analysis of the same data matrix run in ANTHROPAC (Borgatti 1996) .
The plot shows the distribution of 556 plant species across the nine cases, based on the irst two factors produced in the analysis. Species shared by many groups are just left of centre in the plot (e.g., A. catechu, C. nucifera, U. lobata), while those species exclusive to each case are stacked on each other and labelled with a large black circle and the group name, and they can be taken to represent species exclusive of that group's pharmacopoeia (as in Figure 3) .
In general, the shorter the distance between the cores the more similar are the group's lists of medicinal plant species, but one has to be careful because the relationships could be plotted in three dimensions rather than two, which would change the perceived distances between species. The plot highlights the 24 species shared by at least four groups, but not including TOGA. Notice how some of these cluster between different groups' cores, indicating that these are shared by these groups, for instance, Oryza sativa is shown to be shared by central Borneo groups and Dusun.
Based on a presence/absence matrix of 556 plant species. Large black circles are those species exclusive to each group (cores); the closer two cores are to each other, the more similar are their pharmacopoeia. Unlabelled empty diamonds are species shared by less than four groups, labeled black diamonds are species 
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A model of medicinal plant resource pools
On the basis of these data from island Southeast Asia, we can see that as the comparison becomes increasingly wide Contd... 
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ethnographically, geographically, and ecologically; the shared taxa are increasingly concentrated on species of pan-tropical distribution and introduced species. To make sense of the overlaps we have described for local medicinal plant inventories, we suggest that it is useful to use a modiied version of Bates' (1985) plant resource pools hierarchy, distinguishing three pools (or tiers) of medicinal plants.
The primary resource pool is a small group of largely domesticated and cultivated species of general application, including medicinal plants used over a wide ecological and biocultural range. These have, in large part, come to deine a distinctive regional phytomedical repertoire. We suggest that island Southeast Asia is one such region. Here we take 'culturally important medicinal plants' to be those used by a large number of healers for the same categories of local use (Heinrich et al 1998 (Heinrich et al : 1864 . Primary resource pool plants include Areca catechu, Piper betle, Curcuma longa, Senna alata, Costus speciosus, Urena lobata and Cocos nucifera, all found in six of our eight studies. Until we have good quantitative data on number of occasions used for treatment it will be dificult to measure precisely how important these are in treatment, but it may be that they are often ingredients providing a base for other medicinals that carry the greater targeted bioactive burden.
The secondary resource pool or tier comprises species that are widely used, though not shared by all. This will include the majority of common species used, most of which will be cultivated or from disturbed areas. It has been suggested that medicinal plants found only in early successional stages are common elsewhere in Indonesia. In our data, this is true for Senna alata (6/8) and Urena lobata (6/8), but we note that species reported by Caniaga and Siebert (1998: 233) for Ransa as being in this category, and possibly in Wijayakusuma et al. (1992-4) , are not reported for the other studies. This may be because the Caniaga and Siebert study was more thorough, but here we are focussing on common plants in disturbed areas that we would regard as being amongst those less likely to be omitted.
One problem in quantitative work of this kind is that for many users of medicinal plants, all are potentially useful. Some users or healers (e.g. plate/ Figure 5 ) will stress one species, others another. Many species known to other populations are known to Nuaulu, but are not reported as being used [Downloaded free from http://www.conservationandsociety.org on Thursday, January 05, 2017, IP: 80.189.5.13] 356 / Ellen and Puri medicinally. The fact that particular species are not used does not mean that they are not available. The same species may be available locally, or may be obtainable as a branded preparation. Thus, Melaleuca leucadendra (L.) L. is widely known on Seram (and nearby Buru) but the species is only reported in the lists used for Alune, and then as the purchased distillate. There are many species serving the same medicinal purpose, and those indicated locally may be used out of habit and availability, even though other species are known to have the same effect are present. The tertiary resource pool contains fewer plants, most of which are still from disturbed vegetation, but with a higher proportion from primary vegetation zones. A greater proportion of species will be unique to the locality. Tertiary resource pool plants in our data are those often found in only one study and which are most likely to contain species harvested from least disturbed vegetation. There are more of these reported for Ransa than for any of the others.
In many cases tertiary resource pool medicinals are related species of the same genus with the same therapeutic effect. There are at least 25 instances of substitution between the Borneo studies and 33 in the Seram studies. On the other hand, different species of the same genus may be harvested by the same population. This was found to be the case for nine genera in the Seram populations, and for 65 genera in the Borneo populations, relecting higher overall biodiversity. In some cases species may be of genera represented in primary and secondary resource pools, often as rarer substitutes of commoner medicinal species. Thus, for Nuaulu Curcuma aurantiaca Zijp. seems to substitute for C. domestica Valeton., although C. domestica may eventually come to replace it through greater selective pressure arising from perceptions of its increased effectiveness.
Tertiary resource pools tend to provide medicines for less common ailments, and although the pool is an important repository for conservation, it does not provide the greater part of peoples everyday plant medicinal needs.
We would expect to ind secondary and tertiary resource pools composed of more local endemics. Indeed, the ratios of species distributed across one, two, and three of the Seram studies approximately correspond to the deinitions of tertiary, secondary, and primary resource pools provided here. The core medicinal lora of any population will contain plants from all three resource pools, but heavily biased towards primary and secondary pools.
CONCLUSION
Medical anthropologists have been criticised for being insufficiently systematic and comprehensive in listing medicinal plants, while ethnobotanists have often provided inadequate socio-cultural and ecological contextual data and interpretation, both to some extent victims of their different methodologies. This is consistent with general critiques of the inadequacy of the conceptual and methodological bridges between medical anthropology and medical ethnobotany (Ellen 2006; Waldstein and Adams 2006; Hsu 2010) , which have made it dificult to attach measures of plant signiicance for particular species that make sense multi-contextually.
Each of the eight field studies examined here was conducted using rather different assumptions and asymmetric methodologies. There is a strong likelihood that using different approaches has biased the data. Thus, in the Ransa study we would expect a higher proportion of forest species from relatively undisturbed areas given the explicit focus on forest plots and specialist healers. Had the study focussed more on consumption of medicines and treatment episodes we would have expected more common and accessible plants (often those from cultivated and disturbed areas nearer the village). Consequently, medicinal species actually used, as measuredsay-by inclusion in treatment episodes, or species culturally considered important in general descriptions of therapeutic practices, have been omitted because of the sampling strategy employed, or because of how a medicinal plant is deined.
In general the comparison indicates the frequent absence of common species that we would otherwise expect to be present. On the other hand, Gollin's study focussed on elucidating in detail the local medical system from a smaller sample of well qualiied Kenyah Leppo' Ke healers, and collected data based [Downloaded free from http://www.conservationandsociety.org on Thursday, January 05, 2017, IP: 80.189.5.13] Conceptualising 'core' medicinal loras / 357 on actual treatments as well. It is therefore not surprising that she has many more uses and many more medicinal plants from cultivated land. Leaman's study is similarly village-focussed though she uses a Western medical classiication to describe plant use, but like the Ransa study, has used a substantial number of informants to be able to quantify both consensus and variation in knowledge of reported uses.
On the basis of our data, it seems plausible to group loras in terms of medicinal plant resource pools, with a core of commonly used plants that are often widely shared regionally, a secondary pool of locally important plants, and a tertiary pool of lesser used species, comprising the greater proportion of endemics. In addition, the simple method proposed for calculating overlapping taxa may have certain advantages, and we are not aware that it has so far been developed widely or systematically. It helps us to identify possible omissions in the lists that we would predict on other grounds, and it begins to reveal patterns which, using the precedent of the plant resource pool model, are useful in comparative work.
Selection of plants in traditional medicine is complex, depending not only on composition of the lora but also on culture-speciic factors (Amiguet et al. 2006) . The method adopted supports the idea of the speciicity of local medicinal loras, with a high proportion of non-overlap at the species level. To more conidently generalise about regularities in patterns of medicinal plant use we need more meta-analyses of larger datasets of medicinal ethnoloras comparing populations within a single region. We also need studies with explicit protocols that are directly comparable.
Finally, evidence for aggregate measurable loss of medicinal species worldwide and of phytomedicinal diversity, and the need to coordinate place-based conservation action (Padoch et al. 1991; Hamilton 2004 ), must not be downplayed. Secondary and tertiary resource pool species in particular are being depleted in island Southeast Asia due to forest conversion, habitat destruction, and over-extraction for commercial jamu and for export (Rifai and Kartawinata 1991) . Moreover, genetic erosion through depletion of local populations of the same species may well potentially lead to loss of additional bioactivity of pharmacological interest (Rifai and Kartawinata 1991: 283) . Our data suggest that, given low levels of overlap in medicinal species, even for populations closely related linguistically, culturally, and ecologically; as is the case with our three Seram studies and the ive Borneo studies, the knowledge of many medicinal species is highly local. Therefore transmission of knowledge is correspondingly precarious. It is precisely where there is overlap between separate domains of use (here, between different medicinal uses and between medicinal and other uses) that knowledge transmission is most robust (Ellen 2009; Ellen and Fischer 2013: 26) , that is in primary and secondary resource pool species.
However, there is little evidence that any of the species listed in the Seram and Borneo studies are under threat for any of these reasons. Although we recognise that there are many beneits in the maintenance of loral diversity, and that habitat loss and over-extraction may have led to the disappearance of some potentially interesting medicinal plants, there is surprisingly little direct evidence for medicinals of any regular importance for local populations in island Southeast Asia having been lost through ecological conversion and over-extraction (Lemmens and Bunyapraphatsara 2003: 24) .
It does the case of plant conservation no good to exaggerate the consequences for genetic erosion in local ethnopharmocopoeias, and it is probably fortunate that most people who do not have regular or suficient access to synthetic drugs can rely on large numbers of local species that are accessible and not in danger of disappearing, partly through processes of inadvertent management and the circulation of plant material throughout the region. While biodiversity loss is evident in the areas where the eight studies were conducted, and while this may impact on some actual and more potential medicinal plants, it is less likely to impact on core traditional pharmocopoeaias, which are disproportionately composed of common plants from cultivated and disturbed areas. 
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